XOMA XOMA Corp

Price (delayed)

$41.7

Market cap

$522.96M

P/E Ratio

25.27

Dividend/share

N/A

EPS

$1.65

Enterprise value

$553.23M

?
Relative Growth: Rel. Growth: 87
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 64
Relative Profitability: Rel. Profitability: 97

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages ...

Highlights
The company's equity rose by 11% QoQ and by 10% YoY
The EPS has grown by 8% from the previous quarter
The company's quick ratio fell by 38% YoY but it rose by 12% QoQ
The revenue has grown by 13% YoY but it has contracted by 7% from the previous quarter

Key stats

What are the main financial stats of XOMA

XOMA stock price

How has the XOMA stock price performed over time
Intraday
0.02%
1 week
-0.1%
1 month
0.77%
1 year
70.97%
YTD
56.83%
QTD
32.93%

Financial performance

How have XOMA's revenue and profit performed over time
Revenue
$48.56M
Gross profit
$48.56M
Operating income
$4.98M
Net income
$19.95M
Gross margin
100%
Net margin
41.1%
The operating income has soared by 118% YoY but it has plunged by 56% from the previous quarter
XOMA's operating margin has soared by 116% YoY but it has plunged by 53% from the previous quarter
The net margin has grown by 16% since the previous quarter
The revenue has grown by 13% YoY but it has contracted by 7% from the previous quarter

Price vs fundamentals

How does XOMA's price correlate with its fundamentals

Growth

What is XOMA's growth rate over time

Valuation

What is XOMA stock price valuation
P/E
25.27
P/B
5.35
P/S
10.21
EV/EBIT
16.78
EV/EBITDA
15.22
EV/Sales
11.39
The EPS has grown by 8% from the previous quarter
XOMA's price to book (P/B) is 84% more than its 5-year quarterly average of 2.9 and 21% more than its last 4 quarters average of 4.4
The company's equity rose by 11% QoQ and by 10% YoY
The stock's P/S is 51% below its 5-year quarterly average of 20.8 but 34% above its last 4 quarters average of 7.6
The revenue has grown by 13% YoY but it has contracted by 7% from the previous quarter

Efficiency

How efficient is XOMA business performance
The ROS has grown by 12% from the previous quarter
XOMA's ROE has increased by 5% from the previous quarter

Dividends

What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XOMA.

Financial health

How did XOMA financials performed over time
XOMA's total assets is 71% greater than its total liabilities
The company's quick ratio fell by 38% YoY but it rose by 12% QoQ
XOMA's current ratio is down by 35% year-on-year but it is up by 7% since the previous quarter
The debt is 34% greater than the equity
The company's debt to equity fell by 15% QoQ
The company's equity rose by 11% QoQ and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.